Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1Classical hematology 1

Conditions

Anemia 3Neoplasms 2Renal Insufficiency, Chronic 1Kidney Failure, Chronic 1

Interventions

Rocuronium 2Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 2ziprasidone 1venetoclax 1saponin QA-21V1 1perflutren 1peginesatide 1hematide 1finerenone 1empagliflozin 1Zolpidem 1Warfarin 1Vecuronium Bromide 1Vancomycin 1Tranexamic Acid 1Tobramycin 1Thalidomide 1Surveys and Questionnaires 1Stem Cell Transplantation 1Standard of Care 1Spironolactone 1Specimen Handling 1Simethicone 1Sevelamer 1Resistance Training 1Quillaja Saponins 1Protein Subunit Vaccines 1Practice Guidelines as Topic 1Polymorphism, Genetic 1Piperacillin, Tazobactam Drug Combination 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Renal Insufficiency, Chronic × hematide × Clear all
NCT00097747 2012-12-21

Safety and Pharmacokinetics of Single Intravenous Doses of Peginesatide in Healthy Volunteers

Affymax

Phase 1 Completed
28 enrolled
Classical hematologyGenitourinary

Anemia, Kidney Failure, Chronic, Neoplasms, Renal Insufficiency, Chronic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡